A randomised controlled study of apre-operative intervention in patients with diabetes undergoing Cardiac Surgery
Not Applicable
Completed
- Conditions
- DiabetesCardiovascular diseaseCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12608000281392
- Lead Sponsor
- Dept. of Endocrinology and Diabetes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
diagnosed type 2 diabetes mellitus
-HbA1c between 6.5% and 10%*
-age 18 years to 79 years
- the capacity to give and accept informed consent to participate in the research
-attendance at pre-admission clinic
- scheduled cardiac surgery (coronary artery bypass surgery +/- valve surgery)
Exclusion Criteria
age under 18 years or >80 years
-chronic renal disease, stage III or IV
-psychosis or psychiatric disorder
-active cancer within last 5 years
-pregnancy (BHCG in urine screening test) or lactation
-inability to provide informed consent (i.e. has an intellectual disability, dementia)
-unable to communicate in English
- additional types of cardiac surgery other than coronary artery bypass surgery +/- valve surgery)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c- this is assessed every 12 weeks by a venous sample blood test (glycosylated haemoglobin). A pre-operative test 6 weeks before cardiac surgery and a repeat 6 weeks after surgery will allow a comparison of HbA1c levels to be made.[6 weeks post operatively. The follow-up is one visit at six-weeks after cardiac surgery.]
- Secondary Outcome Measures
Name Time Method Mastery of diabetes using the Diabetes Empowerment Scale-Short Form questionnaire (DES-SF)[6 weeks post operatively. The follow-up is one visit at six-weeks after cardiac surgery];Problem Areas in Diabetes questionnaire[6 weeks post operatively. The follow-up is one visit at six-weeks after cardiac surgery]